<code id='CF1607AACE'></code><style id='CF1607AACE'></style>
    • <acronym id='CF1607AACE'></acronym>
      <center id='CF1607AACE'><center id='CF1607AACE'><tfoot id='CF1607AACE'></tfoot></center><abbr id='CF1607AACE'><dir id='CF1607AACE'><tfoot id='CF1607AACE'></tfoot><noframes id='CF1607AACE'>

    • <optgroup id='CF1607AACE'><strike id='CF1607AACE'><sup id='CF1607AACE'></sup></strike><code id='CF1607AACE'></code></optgroup>
        1. <b id='CF1607AACE'><label id='CF1607AACE'><select id='CF1607AACE'><dt id='CF1607AACE'><span id='CF1607AACE'></span></dt></select></label></b><u id='CF1607AACE'></u>
          <i id='CF1607AACE'><strike id='CF1607AACE'><tt id='CF1607AACE'><pre id='CF1607AACE'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:685
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug
          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

          DarronCummings/APThebenefitsandrisksofEliLilly’streatmentforAlzheimer’sdiseasewereconfirmedindetaile

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          AI can decode, harness the power of the humane immune system

          AdobeIftheCovid-19pandemichasshownusonething,itishowlittlewereallyknowabouthowthehumanimmunesystemwo